Middle East News Digest
SEE OTHER BRANDS

Your daily news update on the Middle East

Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on May 7, 2025

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

-  Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA -  Lead target and portfolio strategy to be announced mid …

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …

Century Aluminum Company Reports First Quarter 2025 Results

Century Aluminum Company Reports First Quarter 2025 Results

CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its first quarter 2025 results. First Quarter 2025 Financial Results $MM (except shipments and per share data)   Q1 2025   Q4 2024   Aluminum shipments ( …

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Interim Data from Low Dose Cohort in MyPEAKTM-1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History and Seroprevalence Study Highlights …

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress

Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this year New non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio …

Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference

Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference

NEWTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s …

New Canadian Government Signals Potential Immigration Reforms: What to Expect in 2025 and Beyond

New Canadian Government Signals Potential Immigration Reforms: What to Expect in 2025 and Beyond

New Canadian government signals reform across Express Entry, PNP, and student visas; experts urge applicants to act now. MONTREAL, QUEBEC, CANADA, May 7, 2025 /⁨EINPresswire.com⁩/ -- Following the swearing-in of Canada’s new federal government, …

Bessor Announces Changes to the Board

Bessor Announces Changes to the Board

Vancouver, BC, May 07, 2025 (GLOBE NEWSWIRE) -- Bessor Minerals Inc. (TSXV:BST) ("Bessor" or the “Corporation”) announces Mr. Kieran Downes has resigned as a director of the Corporation. Mr. Downes resigned in order to pursue personal interests unrelated …

Health 2.0 Conference Highlights Solutions For The Growing Insurance Fraud

Health 2.0 Conference Highlights Solutions For The Growing Insurance Fraud

The upcoming health event spotlights innovative strategies and expert insights to combat the rising threat of insurance fraud in the healthcare industry. DUBAI, UNITED ARAB EMIRATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- The Health 2.0 Conference, which …

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

PwC and Cynalytica Announce Strategic Partnership to Define the Next Frontier in Industrial Cybersecurity

PwC and Cynalytica Announce Strategic Partnership to Define the Next Frontier in Industrial Cybersecurity

PwC and Cynalytica enter a strategic partnership marking a significant evolution in securing critical infrastructure operational technology (OT) environments. DUBAI, UNITED ARAB EMIRATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- At GISEC Global 2025, PwC and …

AGII Develops Next-Gen Detection Tools for Proactive Blockchain Safety

AGII Develops Next-Gen Detection Tools for Proactive Blockchain Safety

AI-Powered Platform Reinforces Web3 Security with Scalable Real-Time Monitoring Systems SEATTLE, WA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- AGII, a leading AI-driven Web3 platform, has announced the development of its next-generation detection …

مركز أتوس الطبّي يحتفل بخمس عشرة سنة من التميّز في رعاية الأسنان بالدوحة

مركز أتوس الطبّي يحتفل بخمس عشرة سنة من التميّز في رعاية الأسنان بالدوحة

عيادة أسنان أتوس في الدوحة، بقيادة طبيب الاسنان د. فادي مراد، تقدّم حلول فينير وزراعة وتقويم منذ ٢٠١٠ وتواصل الابتكار بخدمات رقمية متقدمة. DOHA, QATAR, QATAR, May 7, 2025 /⁨EINPresswire.com⁩/ -- في قلب العاصمة القطرية، تُعَدّ عيادة أسنان مركز أتوس الطبّي …

Falcon Technic Welcomes First Third-Party Maintenance Client: Bombardier Global 5000

Falcon Technic Welcomes First Third-Party Maintenance Client: Bombardier Global 5000

DUBAI, United Arab Emirates, May 07, 2025 (GLOBE NEWSWIRE) -- Falcon, part of Alex Group Investment, is excited to announce a major development for Falcon Technic, our MRO division (Maintenance, Repair, and Overhaul): we have welcomed our first third-party …

Falcon Expands Fleet with Two New Legacy 650 Aircraft

Falcon Expands Fleet with Two New Legacy 650 Aircraft

DUBAI, United Arab Emirates, May 07, 2025 (GLOBE NEWSWIRE) -- Falcon, part of Alex Group Investment, is proud to announce the addition of two Legacy 650 aircraft to its fleet. These aircraft offer spacious cabins designed for maximum comfort and privacy, …

Scenic Biotech Announces Nature Publication on the Discovery of Drug Target PLA2G15, a Modifier in Lysosomal Disease

Scenic Biotech Announces Nature Publication on the Discovery of Drug Target PLA2G15, a Modifier in Lysosomal Disease

In collaboration with a Stanford University research team, Scenic Biotech identified and characterized PLA2G15 as a novel target in lysosomal storage diseases Amsterdam, the Netherlands, May 07, 2025 – Scenic Biotech, a pioneer in the field of modifier …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service